Leptin and lipid metabolism in chronic kidney failure

Author： Kastarinen H.   Kesaniemi Y. A.   Ukkola O.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.69, Iss.3, 2009-05, pp. : 401-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins Do Not Affect Mineral Metabolism in Chronic Kidney Disease: A Retrospective Analysis

By  

Nephron Clin Pract, Vol. 111, Iss. 4, 2009-03 ,pp. : c236-c239

Karger

Access to resources Recommend Favorite

Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function

By  

Cardiology, Vol. 130, Iss. 1, 2014-11 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

National Kidney Foundation K-DOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease

By  

Clinical Review in Bone and Mineral Metabolism, Vol. 5, Iss. 1, 2007-03 ,pp. : 53-67

Humana Press, Inc

Access to resources Recommend Favorite

Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials

By Nikolic Dragana   Nikfar Shekoufeh   Salari Pooneh   Rizzo Manfredi   Ray Kausik K.   Pencina Michael J.   Mikhailidis Dimitri P.   Toth Peter P.   Nicholls Stephen J.   Rysz Jacek   Abdollahi Mohammad   Banach Maciej    

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 435-451

Informa Healthcare

Access to resources Recommend Favorite

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 790-801

John Wiley & Sons Inc

Access to resources Recommend Favorite